$STLN SEC Filings

Filed On	Filing
02 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Aug 2026	Form 4: Hively Brad, Director Sold 298,853 shares ($1.95M)
21 Aug 2026	144
21 Aug 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
17 Aug 2026	Form 4: Chernett Jorey, 10% owner Disposed of 100 Call Option (STLN 19FEB27 $9C) (Open Market Sale) ($624) · Bought 12,000 shares ($78.5K)
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition CERRITOS, Calif., August 6, 2026 -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended J...
03 Aug 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure
29 Jul 2026	Form 4: Kaushal Mohit, Director Received 33,133 shares as a grant or award
29 Jul 2026	Form 4: McGeorge Anne, Director Received 41,165 shares as a grant or award
29 Jul 2026	Form 4: Pacala Mark L, Director Received 30,120 shares as a grant or award
29 Jul 2026	Form 4: Stolper Mark, Director Received 31,124 shares as a grant or award
29 Jul 2026	Form 4: Tzoumakas Kimberly Jo, Director Received 29,116 shares as a grant or award
29 Jul 2026	Form 4: Hively Brad, Director Received 27,108 shares as a grant or award
29 Jul 2026	Form 4: Johnson Karen Marie, Director Received 31,124 shares as a grant or award
22 Jul 2026	Form 4: Chernett Jorey, 10% owner Bought 18,000 shares ($94.9K)
16 Jul 2026	Form 4: Podnos Yale, Chief Medical Officer Received 23,452 shares by exercise or conversion ($44.6K) · Sold 23,452 shares ($150K) · Acquired 23,452 Stock Option (Right to Buy) (Option Exercise/Conversion) ($44.6K)
14 Jul 2026	144
13 Jul 2026	Form 4: Chernett Jorey, 10% owner Bought 15,000 shares ($87.8K)
09 Jul 2026	Form 4: Tzoumakas Kimberly Jo, Director Received 17,185 shares as a grant or award

Comments